Korczynski Sherry (CIK 2026090) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-11). Recent activity: Buy AQST (8,750 shares), Sell AQST (8,750 shares), Sell AQST (2,714 shares), Sell AQST (2,714 shares), Buy AQST (75,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-11 | Aquestive Therapeutics, Inc. (AQST) | Chief Commercial Officer | Buy | 8,750 | $23,188 |
| 2026-09-11 | Aquestive Therapeutics, Inc. (AQST) | Chief Commercial Officer | Sell | 8,750 | $45,675 |
| 2026-08-17 | Aquestive Therapeutics, Inc. (AQST) | Chief Commercial Officer | Sell | 2,714 | $11,534 |
| 2026-06-09 | Aquestive Therapeutics, Inc. (AQST) | Chief Commercial Officer | Sell | 2,714 | $0 |
| 2026-03-11 | Aquestive Therapeutics, Inc. (AQST) | Chief Commercial Officer | Buy | 75,000 | $0 |
| 2026-03-11 | Aquestive Therapeutics, Inc. (AQST) | Chief Commercial Officer | Sell | 15,741 | $65,640 |
| 2025-08-15 | Aquestive Therapeutics, Inc. (AQST) | Chief Commercial Officer | Buy | 25,000 | $0 |
| 2025-06-10 | Aquestive Therapeutics, Inc. (AQST) | SVP Sales and Marketing | Sell | 2,714 | $9,608 |
来源：SEC Form 4 申报文件 · 截至 2026-09-11